Cyrus Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 09-07-2024
- Paid Up Capital ₹ 1.00 Cr
as on 09-07-2024
- Company Age 46 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit -25.75%
(FY 2022)
- Ebitda -51.63%
(FY 2022)
- Net Worth -10.46%
(FY 2022)
- Total Assets -10.65%
(FY 2022)
About Cyrus Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Roshen Nentin, Firoze Bhathena, and Adil Khambata serve as directors at the Company.
- CIN/LLPIN
U24110MH1978PTC020720
- Company No.
020720
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Oct 1978
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationMumbai, Maharashtra
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cyrus Chemicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Roshen Nentin  | Director | 02-Sep-1999 | Current |
| Firoze Bhathena | Director | 01-Jul-1980 | Current |
| Adil Khambata | Director | 21-Mar-2011 | Current |
Financial Performance and Corporate Structure Insights of Cyrus Chemicals.
Cyrus Chemicals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 25.75% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cyrus Chemicals?
In 2020, Cyrus Chemicals had a promoter holding of 61.96% and a public holding of 38.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shapoorji Pallonji And Company Private LimitedActive 81 years 10 monthsRoshen Nentin and Firoze Bhathena are mutual person
- Pallonji Shapoorji And Company Private LimitedActive 73 years 6 months
Roshen Nentin is a mutual person
S C Finance And Investments Private LimitedActive 45 years 3 monthsRoshen Nentin and Firoze Bhathena are mutual person
Mistry Advanced Nutrition Centre Private LimitedActive 6 years 2 monthsRoshen Nentin is a mutual person
- Cyrus Investments Private LimitedActive 101 years 9 months
Roshen Nentin and Firoze Bhathena are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cyrus Chemicals?
Unlock and access historical data on people associated with Cyrus Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cyrus Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cyrus Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
